Glenn Oclassen

Former Chairman of the Board, President & Chief Executive Officer at Paratek Pharmaceuticals Inc.

Glenn Oclassen

Glenn Oclassen

Former Chairman of the Board, President & Chief Executive Officer at Paratek Pharmaceuticals Inc.

Overview
Career Highlights

PharmaQuest Corp.
Neutrogena Corporation
Paratek Pharmaceuticals Inc.

RelSci Relationships

221

Number of Boards

8

Birthday

1943

Age

76

Relationships
RelSci Relationships are individuals Glenn Oclassen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder, Managing Director & General Partner at Montreux Equity Partners

Relationship likelihood: Strong

Former Professional at GenPharm International, Inc.

Relationship likelihood: Strong

Former President, Chief Executive & Operating Officer at Genentech, Inc.

Relationship likelihood: Strong

Managing Director at Four Oaks Partners LLC

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Former Co-Founder & Partner at New Leaf Venture Partners LLC

Relationship likelihood: Strong

Chief Executive Officer at Paratek Pharmaceuticals Inc.

Relationship likelihood: Strong

Chief Executive Officer at ZP Opco, Inc.

Relationship likelihood: Strong

President & Chief Operating Officer at Paratek Pharmaceuticals Inc.

Relationship likelihood: Strong

Vice President, Operations at Paratek Pharmaceuticals Inc.

Relationship likelihood: Strong

Paths to Glenn Oclassen
Potential Connections via
Relationship Science
You
Glenn Oclassen
Former Chairman of the Board, President & Chief Executive Officer at Paratek Pharmaceuticals Inc.
Education
B.S. in Zoology
Class of 1965

San Diego State University (SDSU, State) is a public research university in San Diego, and is the largest and oldest higher education facility in San Diego County. Founded in 1897 as San Diego Normal School, it is the third-oldest university in the 23-member California State University (CSU), and is considered the flagship campus of the entire system. SDSU has a student body of more than 34,000 and an alumni base of more than 260,000. The university awards 189 types of bachelor's degrees, 91 different master's degrees, 22 types of doctoral degrees including Ed.D, Ed.S, DPT, J.D., Au.D, Ph.D. programs in collaboration with Claremont Graduate University,UC Davis, UC Riverside, UCSD, and UCSB. The university also offers 26 different teaching credentials.SDSU offers more doctoral degrees than any other campus in the California State University system.

Memberships
Member
Current

North American Clinical Dermatologic Society, Inc. operates as a non-profit organization which provides clinical dermatology educational opportunities by arranging annual meetings with academic centers and societies worldwide. The company was founded by Charles A. Oclassen in 1959 and is headquartered in Springfield, PA.

Career History
Chairman of the Board, President & Chief Executive Officer
2009 - 2014

Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases.

President & Chief Executive Officer
2001 - 2009

Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA.

Founder
1997 - 1999
Boards & Committees
Member, Board of Directors
2015 - Current

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product VP-102, is a proprietary topical therapy used in common skin indications including Molluscum contagiosum and Verruca Vulgaris. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Director
2009 - 2009

Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea's in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA.

Chairman & Chief Executive Officer
2009 - 2014

Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases.

Non-Physician Member, Executive Committee
Prior

THE PURPOSES OF THE ORGANIZATION IS THE FUNDING OF RESEARCH IN THE FIELD OF DERMATOLOGY IN ORDER TO ADVANCE PATIENT CARE AND HELP DEVELOP AND RETAIN TOMORROW'S TEACHERS AND CLINICAL LEADERS IN THE SPECIALTY.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$25K +
2015

THE PURPOSES OF THE ORGANIZATION IS THE FUNDING OF RESEARCH IN THE FIELD OF DERMATOLOGY IN ORDER TO ADVANCE PATIENT CARE AND HELP DEVELOP AND RETAIN TOMORROW'S TEACHERS AND CLINICAL LEADERS IN THE SPECIALTY.

$50K - $75K
2013

THE PURPOSES OF THE ORGANIZATION IS THE FUNDING OF RESEARCH IN THE FIELD OF DERMATOLOGY IN ORDER TO ADVANCE PATIENT CARE AND HELP DEVELOP AND RETAIN TOMORROW'S TEACHERS AND CLINICAL LEADERS IN THE SPECIALTY.

$25K +
2012

THE PURPOSES OF THE ORGANIZATION IS THE FUNDING OF RESEARCH IN THE FIELD OF DERMATOLOGY IN ORDER TO ADVANCE PATIENT CARE AND HELP DEVELOP AND RETAIN TOMORROW'S TEACHERS AND CLINICAL LEADERS IN THE SPECIALTY.

Transactions
Details Hidden

purchases Paratek Pharmaceuticals, Inc. (Inactive) from Aisling Capital, Omega Funds, HBM Healthcare Investments AG

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Glenn Oclassen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Glenn Oclassen's profile does not indicate a business or promotional relationship of any kind between RelSci and Glenn Oclassen.